πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7405202

CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

Regents of the University of Minnesota Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7402595

JNK inhibitor

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7399606

Methods for identifying IΞΊB Kinase (IKK) inhibitors

The Regents of the University of California Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390815

Pyrazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7390808

Inhibitors of GSK-3 and crystal structures of GSK-3Ξ² protein and protein complexes

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388002

Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

BioCryst Pharmaceuticals, Inc. Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388074

Mutant plasminogen activator-inhibitor type 1 (PAI-1) and uses thereof

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7388017

Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7381825

Histone deacetylase inhibitors

Takeda San Diego, Inc. Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378552

Monoamine re-uptake inhibitors and methods relating thereto

Neurocrine Biosciences, Inc. Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7378422

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375079

Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375074

Body weight gain inhibitor

Takeda Chemical Industries Ltd. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7374770

Topical composition for follicular delivery of an ornithine decarboxylase inhibitor

SkinMedica, Inc. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7375228

Histone deacetylase inhibitors

Takeda San Diego, Inc. Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7371372

Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7368452

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365072

Inhibitors of p38

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7365092

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7361665

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358259

HCV inhibitors and methods of using them

Rigel Pharmaceuticals, Inc. Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7358258

Prodrugs of an ERK protein kinase inhibitor

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted